VF
VTVT icon

Virtu Financial’s vTv Therapeutics VTVT Stock Holding History

Virtu Financial’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-832
Closed -$27K – 2089
2023
Q1 		$27K Buy
832
+267
+47% +$9.06K ﹤0.01% 1190
2022
Q4 		$15K Sell
565
-534
-49% -$17.7K ﹤0.01% 1325
2022
Q3 		$43K Buy
1,099
+135
+14% +$5.31K ﹤0.01% 1236
2022
Q2 		$29K Buy
+964
New +$24.7K ﹤0.01% 1261
2022
Q1 		– Sell
-2,362
Closed -$94K – 2077
2021
Q4 		$94K Sell
2,362
-180
-7% -$9.66K 0.01% 1155
2021
Q3 		$156K Buy
+2,542
New +$192K 0.01% 994
2021
Q1 		– Sell
-942
Closed -$70K – 2060
2020
Q4 		$70K Buy
+942
New +$72.2K 0.01% 1152
2020
Q3 		– Sell
-3,860
Closed -$347K – 1559
2020
Q2 		$347K Buy
+3,860
New +$381K 0.04% 500
2019
Q4 		– Sell
-1,914
Closed -$119K – 1898
2019
Q3 		$119K Buy
1,914
+1,185
+163% +$66.9K 0.01% 1058
2019
Q2 		$42K Buy
+729
New +$43.8K ﹤0.01% 1267

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
V
Veritable Wilmington, Delaware $6.46B AUM 17.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return

Virtu Financial's VTVT Position: Q2 2023 in Review

Virtu Financial sold out of vTv Therapeutics (VTVT) in Q2 2023, closing a stake of 832 shares — an estimated $27K sold.

Virtu Financial first reported a position in VTVT in Q2 2019 and held it in 10 quarters. The position peaked at $347K in Q2 2020. 20 funds tracked by Wall St. Rank hold VTVT as of Q2 2023.

  • Virtu Financial reported no remaining vTv Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 832 vTv Therapeutics shares in Q2 2023, an estimated $27K.
  • Virtu Financial first reported a position in vTv Therapeutics in Q2 2019 and held it in 10 quarters.
  • Virtu Financial's vTv Therapeutics position peaked at $347K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.